Flagship Pioneering — which has built a reputation for stocking its portfolio companies with Big Pharma vets — has raided J&J again for a dealmaker. Most recently, Jim Jogerst was senior director of business development at Janssen’s infectious diseases and vaccines business. He will now become Rubius Therapeutics’ chief business officer, tasked with identifying partnerships, … Continue reading Flagship woos another Big Pharma BD exec to biotech. Red blood cell therapies anyone?